MERCK Kommanditgesellschaft auf Aktien – SIX:MER.SW

Financial Health
0
1
2
3
4
5
6
7
8
9

MERCK Kommanditgesellschaft auf Aktien key metrics

Market Cap
N/A
Enterprise value
53.49B
P/E
14.19
EV/Sales
2.40
EV/EBITDA
8.17
Price/Sales
2.00
Price/Book
1.71
PEG ratio
1.60
EPS
7.67
Revenue
22.23B
EBITDA
6.54B
Income
3.33B
Revenue Q/Q
8.57%
Revenue Y/Y
12.92%
Profit margin
14.96%
Oper. margin
20.12%
Gross margin
61.65%
EBIT margin
20.12%
EBITDA margin
29.43%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

MERCK Kommanditgesellschaft auf Aktien stock price history

MERCK Kommanditgesellschaft auf Aktien stock forecast

MERCK Kommanditgesellschaft auf Aktien financial statements

MERCK Kommanditgesellschaft auf Aktien (SIX:MER.SW): Profit margin
Mar 2022 5.19B 884M 17.01%
Jun 2022 5.56B 870M 15.63%
Sep 2022 5.80B 926M 15.95%
Dec 2022 5.66B 659M 11.64%
1.81%
Yield TTM
MERCK Kommanditgesellschaft auf Aktien (SIX:MER.SW): Payout ratio
Payout ratio 24.22%
MERCK Kommanditgesellschaft auf Aktien (SIX:MER.SW): Dividend Yield
2018 1.91%
2019 0.4%
2020 0.41%
2021 0.42%
2022 0.53%
MERCK Kommanditgesellschaft auf Aktien (SIX:MER.SW): Debt to assets
Mar 2022 46164000000 23.24B 50.35%
Jun 2022 48717000000 22.68B 46.57%
Sep 2022 50933000000 22.59B 44.36%
Dec 2022 48526000000 22.52B 46.41%
MERCK Kommanditgesellschaft auf Aktien (SIX:MER.SW): Cash Flow
Mar 2022 840M -1.08B -315M
Jun 2022 852M -786M 167M
Sep 2022 1.55B -622M -909M
Dec 2022 1.01B -246M -498M

MERCK Kommanditgesellschaft auf Aktien alternative data

MERCK Kommanditgesellschaft auf Aktien (SIX:MER.SW): Employee count
Aug 2023 59,308
Sep 2023 59,308
Oct 2023 59,308
Nov 2023 59,308
Dec 2023 59,308
Jan 2024 59,308
Feb 2024 59,308
Mar 2024 59,308
Apr 2024 59,308
May 2024 59,308
Jun 2024 59,308
Jul 2024 59,308

MERCK Kommanditgesellschaft auf Aktien other data

  • When is MERCK Kommanditgesellschaft auf Aktien's next earnings date?

    Unfortunately, MERCK Kommanditgesellschaft auf Aktien's (MER.SW) next earnings date is currently unknown.

  • Does MERCK Kommanditgesellschaft auf Aktien pay dividends?

    Yes, MERCK Kommanditgesellschaft auf Aktien pays dividends and its trailing 12-month yield is 1.81% with 24% payout ratio. The last MERCK Kommanditgesellschaft auf Aktien stock dividend of undefined was paid on 6 Sep 2025.

  • What is MERCK Kommanditgesellschaft auf Aktien's stock symbol?

    MERCK Kommanditgesellschaft auf Aktien is traded on the SIX under the ticker symbol "MER.SW".

  • What is MERCK Kommanditgesellschaft auf Aktien's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of MERCK Kommanditgesellschaft auf Aktien?

    Shares of MERCK Kommanditgesellschaft auf Aktien can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does MERCK Kommanditgesellschaft auf Aktien have?

    As Jul 2024, MERCK Kommanditgesellschaft auf Aktien employs 59,308 workers.

  • When MERCK Kommanditgesellschaft auf Aktien went public?

    MERCK Kommanditgesellschaft auf Aktien is publicly traded company for more then 10 years since IPO on 2 Dec 2014.

  • What is MERCK Kommanditgesellschaft auf Aktien's official website?

    The official website for MERCK Kommanditgesellschaft auf Aktien is merckgroup.com.

  • How can i contact MERCK Kommanditgesellschaft auf Aktien?

    MERCK Kommanditgesellschaft auf Aktien can be reached via phone at +49 6151 720.

MERCK Kommanditgesellschaft auf Aktien company profile:

MERCK Kommanditgesellschaft auf Aktien

merckgroup.com
Exchange:

SIX

Full time employees:

59,308

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Frankfurter Strasse 250
Darmstadt, 64293

:
:
: